Literature DB >> 7591088

Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies.

R Manetti1, P Massari, D Burroni, M de Bernard, A Marchini, R Olivieri, E Papini, C Montecucco, R Rappuoli, J L Telford.   

Abstract

We have attempted to express the Helicobacter pylori vacuolating cytotoxin in Escherichia coli. Although the 95-kDa VacA polypeptide was expressed abundantly, it completely lacked any biological activity. In addition, this material failed to induce neutralizing antibodies after immunization of rabbits. In contrast, highly purified high-molecular-mass cytotoxin from the supernatant of H. pylori cultures was active in a HeLa cell assay and effectively induced a neutralizing response in rabbits. Neutralizing sera were shown to contain a high proportion of antibodies which recognized conformational epitopes found only on the native toxin. The data indicate that toxin-neutralizing epitopes are conformational and that potential vaccines based on the cytotoxin may benefit from the use of the intact molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591088      PMCID: PMC173637          DOI: 10.1128/iai.63.11.4476-4480.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Mutants of pertussis toxin suitable for vaccine development.

Authors:  M Pizza; A Covacci; A Bartoloni; M Perugini; L Nencioni; M T De Magistris; L Villa; D Nucci; R Manetti; M Bugnoli
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

2.  Purification and characterization of the vacuolating toxin from Helicobacter pylori.

Authors:  T L Cover; M J Blaser
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

3.  The crystal structure of pertussis toxin.

Authors:  P E Stein; A Boodhoo; G D Armstrong; S A Cockle; M H Klein; R J Read
Journal:  Structure       Date:  1994-01-15       Impact factor: 5.006

4.  Optimized conditions for the fermentation of Helicobacter pylori and production of vacuolating cytotoxin.

Authors:  A Marchini; P Massari; R Manetti; R Olivieri
Journal:  FEMS Microbiol Lett       Date:  1994-11-15       Impact factor: 2.742

Review 5.  Production of a cytotoxin by Helicobacter pylori.

Authors:  R D Leunk
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

6.  Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein.

Authors:  W Schmitt; R Haas
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

Review 7.  Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines.

Authors:  J L Telford; A Covacci; P Ghiara; C Montecucco; R Rappuoli
Journal:  Trends Biotechnol       Date:  1994-10       Impact factor: 19.536

8.  Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.

Authors:  T L Cover; M K Tummuru; P Cao; S A Thompson; M J Blaser
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

9.  Development of a mouse model of Helicobacter pylori infection that mimics human disease.

Authors:  M Marchetti; B Aricò; D Burroni; N Figura; R Rappuoli; P Ghiara
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  36 in total

1.  How the loop and middle regions influence the properties of Helicobacter pylori VacA channels.

Authors:  F Tombola; C Pagliaccia; S Campello; J L Telford; C Montecucco; E Papini; M Zoratti
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Expression of Helicobacter pylori vacuolating toxin in Escherichia coli.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS.

Authors:  D Kuck; B Kolmerer; C Iking-Konert; P H Krammer; W Stremmel; J Rudi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Deletion of the major proteolytic site of the Helicobacter pylori cytotoxin does not influence toxin activity but favors assembly of the toxin into hexameric structures.

Authors:  D Burroni; P Lupetti; C Pagliaccia; J M Reyrat; R Dallai; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Binding of the Helicobacter pylori vacuolating cytotoxin to target cells.

Authors:  P Massari; R Manetti; D Burroni; S Nuti; N Norais; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

6.  Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol.

Authors:  M de Bernard; D Burroni; E Papini; R Rappuoli; J Telford; C Montecucco
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity.

Authors:  C Pagliaccia; M de Bernard; P Lupetti; X Ji; D Burroni; T L Cover; E Papini; R Rappuoli; J L Telford; J M Reyrat
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Polyphenols reduce gastritis induced by Helicobacter pylori infection or VacA toxin administration in mice.

Authors:  P Ruggiero; F Tombola; G Rossi; L Pancotto; L Lauretti; G Del Giudice; M Zoratti
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

9.  Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin.

Authors:  E Papini; B Satin; N Norais; M de Bernard; J L Telford; R Rappuoli; C Montecucco
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.

Authors:  Masaaki Nakayama; Junzo Hisatsune; Eiki Yamasaki; Hajime Isomoto; Hisao Kurazono; Masanori Hatakeyama; Takeshi Azuma; Yoshio Yamaoka; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  J Biol Chem       Date:  2008-11-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.